Tetracycline Knocking the Door, Once Again
##plugins.themes.academic_pro.article.main##
Abstract
This editorial highlights the hidden potentials of a long forgotten antibiotic tetracycline and urges the practioners to explore its clinical usefulness.
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Sharma, V. (2014). Tetracycline Knocking the Door, Once Again. International Journal of Medical and Dental Sciences, 3(2), 386–387. https://doi.org/10.19056/ijmdsjssmes/2014/v3i2/81255
References
- Birkedal Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontal 1993;64:474.
- Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr opin Periodontal 1996;3:85.
- Preshaw PM, Novase MJ, Mellonig J, Magnusson I, Polson A, Giannobile WV, et al. Modified release subantimicrobial dose doxycycline enhances scaling and root planning in subjects with periodontal disease. J Periodontal 2008;79(3):440-452.
- Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Kor J Ophthalmol 2005 Dec;19(4):258-63.
- Wang L, Tsang H, Coroneo M. Treatment of recurrent corneal erosion syndrome using the combination of oral doxycycline and topical corticosteroid. Clin Exp Ophthalmol 2008 Feb;36(1):8-12.
- Liang D. Low-dose doxycycline in the treatment of corneal burn. Identifier: NCT01886560. Available at: http://clinicaltrials.gov/show/NCT01886560 . Accessed May 8, 2014.